|
Seth J. Orlow, MD, PhD, Board Member Seth J. Orlow is a Venture Partner with Easton Capital Partners, where he has focused on healthcare investing since 2001. Seth is Chairman of the Department of Dermatology at New York University School of Medicine where he is also a Professor of Cell Biology and Pediatrics. He was a co-founder of Anaderm, a cosmeceutical drug discovery company acquired by Pfizer in 2001, and of Ivrea Pharmaceuticals, a company developing high impact prescription dermatologic therapies. In addition to serving on the board of Ivrea, he represents Easton on the boards of Protez Pharmaceuticals and Transave Inc. Seth received his AB magna cum laude from Harvard, and his MD and PhD (Molecular Pharmacology) from the Albert Einstein College of Medicine. He completed his residency and fellowship training in Dermatology at Yale. | 